I had a quick read of the Bell Potter report
as before they say that PNV is entering a crowded field one where 60 graft products and 70 hernia products are already available
with due respect to BP this statement simply reflects a basic misunderstanding about how medicine works
because in medicine all doctors will use the gold standard (if one exists)
so the fact there are so many competing products tells me that none of them are much good and that a breakthrough technology (BTM) will sweep them aside ...
finally, I would suggest that the reference to "low hanging fruit" is simply inane
I had a quick read of the Bell Potter reportas before they say...
-
- There are more pages in this discussion • 7,699 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |